This study evaluates the Freedom SCS (spinal cord stimulation) System for the treatment of chronic back and leg pain. Patients who have been diagnosed with failed back surgery syndrome (FBSS) will receive a stimulator device for treatment of their pain.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
45
Amphia Ziekenhuis
Oosterhout, North Brabant, Netherlands
Percentage of pain relief experienced in the area of pain identified at baseline compared to 12 months post full implant of the Freedom SCS system.
Self reported pain intensity measured by the Visual Analog Scale (VAS)
Time frame: 12 months
Incidence and severity of device related adverse events during the study.
Time frame: Up to 12 months
To assess compliance data to indicate usability of the device.
Questionnaire
Time frame: 12 Months
To assess the implanters' experience with the device.
Questionnaire
Time frame: Average of 7 days after implant
Patient satisfaction with treatment.
Questionnaire
Time frame: 12 Months
Reduced visits to health care institutes for chronic back and leg pain.
Questionnaire
Time frame: 12 Months
Improved work status.
Questionnaire
Time frame: 12 Months
Improved quality of life function via the ODI and EQ-5D questionnaires
ODI and EQ-5D Questionnaires
Time frame: 12 Months
Reduction in use of analgesics
Time frame: 12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Reduced operating theater time
Review of hospital records
Time frame: Average of 7 days after implant
Reduced skin to skin time
Review of hospital records
Time frame: Average of 7 days after implant
Reduced skin to fluoroscope time
Review of hospital records
Time frame: Average of 7 days after implant
To monitor non-device and non-SCS-related adverse events
Time frame: Up to 12 months